Cargando…

Do critically ill patients with AKI benefit from furosemide? Further real-word evidence from a large multi-center database

Detalles Bibliográficos
Autores principales:	Gao, Shaowei, Yang, Lu, Wang, Zhongxing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249379/ https://www.ncbi.nlm.nih.gov/pubmed/32450912 http://dx.doi.org/10.1186/s13054-020-02905-7

Ejemplares similares

Nutrition Support in Critically Ill Patients with AKI
por: Ramakrishnan, Nagarajan, et al.
Publicado: (2020)

Furosemide is associated with acute kidney injury in critically ill patients
por: Levi, T.M., et al.
Publicado: (2012)

Fluid accumulation increases the risk of AKI progression and death in critically ill patients with early AKI
por: Raimundo, MR, et al.
Publicado: (2014)

Immediate effects of a bolus of furosemide on hemodynamics in critically ill patients
por: Markou, N, et al.
Publicado: (2003)

The use of furosemide in critically ill trauma patients: A retrospective review
por: Yeh, Daniel Dante, et al.
Publicado: (2014)

Response to different furosemide doses predicts AKI progression in ICU patients with elevated plasma NGAL levels
por: Matsuura, Ryo, et al.
Publicado: (2018)

Epidemiology of AKI: Utilizing Large Databases to Determine the Burden of AKI
por: Sawhney, Simon, et al.
Publicado: (2017)

Continuous versus bolus furosemide therapy in critically ill patients with fluid overload
por: Ostermann, M, et al.
Publicado: (2002)

Hepatic drug metabolism by CYP2D6 in critically ill adults with AKI: effect of phenotype and AKI severity
por: Lane, K, et al.
Publicado: (2015)

Evaluation of Factors Associated with Hypermetabolism and Hypometabolism in Critically Ill AKI Patients
por: de Góes, Cassiana R., et al.
Publicado: (2018)

Urine Complement Factor Ba Is Associated with AKI in Critically Ill Children
por: Stenson, Erin K., et al.
Publicado: (2023)

Association between furosemide administration and outcomes in critically ill patients with acute kidney injury
por: Zhao, Guang-ju, et al.
Publicado: (2020)

Cumulative Doses Predict the Risk of Furosemide-Induced Electrolyte Abnormalities in Critically Ill Neonates
por: Sridharan, Kannan, et al.
Publicado: (2022)

Effect of First Trough Vancomycin Concentration on the Occurrence of AKI in Critically Ill Patients: A Retrospective Study of the MIMIC-IV Database
por: Li, Longzhu, et al.
Publicado: (2022)

Predictors of renal recovery in critically ill patients with AKI: observations from the ongoing FBI clinical trial
por: Robinson, S, et al.
Publicado: (2015)

Volume of distribution as an early predictor of vancomycin-induced AKI in critically ill patients
por: Ghasemiyeh, Parisa, et al.
Publicado: (2023)

Association Between Furosemide Exposure and Clinical Outcomes in a Retrospective Cohort of Critically Ill Children
por: Dai, Xiaomei, et al.
Publicado: (2021)

Furosemide exacerbated the impairment of renal function, oxygenation and medullary damage in a rat model of renal ischemia/reperfusion induced AKI
por: Dilken, Olcay, et al.
Publicado: (2023)

Impact of ideal versus estimated body weight on haemofiltration dosing in critically ill patients with AKI
por: Fischer, F, et al.
Publicado: (2014)

ICU survival and need of renal replacement therapy with respect to AKI duration in critically ill patients
por: Truche, A. S., et al.
Publicado: (2018)

Serum IL-17 levels are higher in critically ill patients with AKI and associated with worse outcomes
por: Collett, Jason A., et al.
Publicado: (2022)

Neurological Impairment in Critically Ill Patients on Dialysis: Research Letter for the INCOGNITO-AKI Feasibility Study
por: Jawa, Natasha A., et al.
Publicado: (2023)

Goal-directed diuresis: A case — control study of continuous furosemide infusion in critically ill trauma patients
por: Yeh, Daniel Dante, et al.
Publicado: (2015)

Subclinical AKI is still AKI
por: Ronco, Claudio, et al.
Publicado: (2012)

Urinary TIMP-2 and IGFBP7 elevate early in critically ill postoperative patients that develop AKI
por: Honore, P, et al.
Publicado: (2015)

Trial of Furosemide to Prevent Acute Kidney Injury in Critically Ill Children: A Double-Blind, Randomized, Controlled Trial
por: Abraham, Shilpa, et al.
Publicado: (2021)

COVID-19 and AKI: Where Do We Stand?
por: Palevsky, Paul M.
Publicado: (2021)

A further look at ageing and word predictability effects in Chinese reading: Evidence from one-character words
por: Zhao, Sainan, et al.
Publicado: (2020)

Early short-course corticosteroids and furosemide combination to treat non-critically ill COVID-19 patients: An observational cohort study
por: Kevorkian, Jean-Philippe, et al.
Publicado: (2021)

AKI-CLIF-SOFA: a novel prognostic score for critically ill cirrhotic patients with acute kidney injury
por: Sun, Dan-Qin, et al.
Publicado: (2017)

Incidence, timing and outcome of AKI in critically ill patients varies with the definition used and the addition of urine output criteria
por: Koeze, J., et al.
Publicado: (2017)

POS-027 Critical illness and systemic inflammation are key risk factors of severe AKI in patients with COVID-19
por: HARDENBERG, J.H.B., et al.
Publicado: (2021)

Relationship between CRP Albumin Ratio and the Mortality in Critically Ill Patients with AKI: A Retrospective Observational Study
por: Wang, Jiajia, et al.
Publicado: (2021)

Do Metastatic Kidney Cancer Patients Benefit From Cytoreductive Nephrectomy? A Real-World Retrospective Study From the SEER Database
por: Li, Cheng, et al.
Publicado: (2021)

Recovery from AKI by KDIGO criteria
por: Schrijvers, D, et al.
Publicado: (2014)

Intravenous furosemide in decompensated heart failure: do not protocolize dosing but the desired effect!
por: de Grooth, Harm-Jan S, et al.
Publicado: (2014)

Oral Furosemide and Hydrochlorothiazide/Amiloride versus Intravenous Furosemide for the Treatment of Resistant Nephrotic Syndrome
por: Frățilă, Georgiana, et al.
Publicado: (2023)

UK Science to Benefit from Further Investment in HPC
Publicado: (2009)

The utility of neutrophil gelatinase-associated Lipocalin (NGAL) as a marker of acute kidney injury (AKI) in critically ill patients
por: Khawaja, Shabnum, et al.
Publicado: (2019)

An NMR crystallography investigation of furosemide
por: Zilka, Miri, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3ikcrk1pf06murfosgctplkv72